Eleftherios P. Mamounas

Trastuzumab plus Adjuvant Chemotherapy for Operable HER2-Positive Breast Cancer

Edward H. Romond, Edith A. Perez, John Bryant et al. · New England Journal of Medicine · 2005 · 5.4K citations · Full text

Medicine, Oncology, Pharmacotherapy +17

Trastuzumab Emtansine for Residual Invasive HER2-Positive Breast Cancer

Gϋnter von Minckwitz, Chiun‐Sheng Huang, Max S. Mano et al. · New England Journal of Medicine · 2018 · 2.6K citations · Full text

Medicine, Oncology, Pharmacology +17

Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trial

David N. Krag, Stewart Anderson, Thomas B. Julian et al. · The Lancet Oncology · 2010 · 1.9K citations · Full text

Medicine, Oncology, Surgery +17

Preoperative Chemotherapy: Updates of National Surgical Adjuvant Breast and Bowel Project Protocols B-18 and B-27

Priya Rastogi, Stewart Anderson, Harry D. Bear et al. · Journal of Clinical Oncology · 2008 · 1.8K citations

Medicine, Oncology, Surgery +16

The Effect on Tumor Response of Adding Sequential Preoperative Docetaxel to Preoperative Doxorubicin and Cyclophosphamide: Preliminary Results From National Surgical Adjuvant Breast and Bowel Project Protocol B-27

Harry D. Bear, Stewart Anderson, Ann Brown et al. · Journal of Clinical Oncology · 2003 · 1.1K citations

Medicine, Oncology, Surgery +17